Sign in
6-K

Report of Foreign Issuer

Zoar Ltd Filed Acc 0001493152-26-053003

Zoar Limited Completes Business Combination with Impact Biomedical Inc.

  • Zoar Limited ordinary shares are expected to begin trading on the NYSE American under the ticker symbol “ZOAR” on November 18, 2026.

From the SEC's structured data for this filing

Loading form6-k.htm…